After the first transplant test were done to measure progress. Results were no as good as hoped for or predicted by SCCA staff.
Two transplants have been in the plan since the initial stages of Michael's treatments at SCCA. He had hoped to get by with just one transplant using his own stem cells and return to a normal life style. After considerable thought Michael chose to go ahead with the second transplant. Plan or Part B depending on where you sit.
The second transplant will use donor cells (Allogenic) and the situation requires rapid action, thus limiting the cancers opportunity to grow additional cells. Process is under way and Michael will start chemo on March 28th (3 days) then on the fifth day receive the donor stem cells. The donor's stem cells have a very high grade for matching Michael's, 100% in many areas to include blood type. Better results come with higher risks; therefore, Michael will be closely monitored and provided with all types of meds that come under the heading of, Just In Case.
Sunday, February 15, 2009
Sunday, February 8, 2009
Results and Plans
Michael has continued to recover from the effects of chemo and to develop new cells. Actually, he is growing bone marrow and blood cells at a very rapid rate. Much faster than anticipated.
At this point the SCCA staff tested Michael's blood for cancer levels. At this point Michael did not exceed expectations and had a measurable level of cancer, higher than forecast. The medical staff explained this as being caused a late diagnosis and dealing with the second most aggressive type of myeloma.
Now it is decision time. Michael may stop the transplant process, now, and work to keep the myeloma at depressed levels with medication. Or, he may proceed with the second transplant, using donor stem cells and has been planned all along. This donor transplant (allogenic), following a transplant of Michael's own stem cells, offers better results. Along with better results come higher risk, some of which are most serious and possibly fatal.
After researching and reviews with the SCCA staff, Michael has decided to continue the treatment schedule and go forward with the donor transplant!
At this point the SCCA staff tested Michael's blood for cancer levels. At this point Michael did not exceed expectations and had a measurable level of cancer, higher than forecast. The medical staff explained this as being caused a late diagnosis and dealing with the second most aggressive type of myeloma.
Now it is decision time. Michael may stop the transplant process, now, and work to keep the myeloma at depressed levels with medication. Or, he may proceed with the second transplant, using donor stem cells and has been planned all along. This donor transplant (allogenic), following a transplant of Michael's own stem cells, offers better results. Along with better results come higher risk, some of which are most serious and possibly fatal.
After researching and reviews with the SCCA staff, Michael has decided to continue the treatment schedule and go forward with the donor transplant!
Subscribe to:
Posts (Atom)